Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lexagene Holdings Inc LXXGQ

Healthcare Medical Devices
Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in... see more

Recent & Breaking News (GREY:LXXGQ)

LexaGene (TSXV:LXG) initiates program to identify UK and South African COVID sequences

Isabella Zavarise January 14, 2021

LexaGene Initiates Program to Identify UK and South African COVID Sequences

GlobeNewswire January 13, 2021

LexaGene to Present at Upcoming SNN Network and H.C. Wainwright Bioconnect 2021 Virtual Events

GlobeNewswire January 6, 2021

Keynotes, Educational Panels and 42 Canadian-Listed Public Companies Presenting at the SNN Network Canada Virtual Event - January 6-7, 2021

Accesswire January 5, 2021

LexaGene Starts FDA EUA Study for Point-of-Care COVID-19 Testing

GlobeNewswire December 30, 2020

LexaGene to Place MiQLab Systems at Two Leading Specialty and Emergency Veterinary Care Hospitals

GlobeNewswire December 17, 2020

LexaGene Receives Purchase Order for MiQLab from Ethos Discovery

GlobeNewswire December 15, 2020

LexaGene to Participate at the 13th Annual LD Micro Main Event Conference

GlobeNewswire December 9, 2020

LexaGene Places MiQLab System at the University of Pennsylvania's School of Veterinary Medicine

GlobeNewswire November 18, 2020

LexaGene Receives Purchase Order from a Multinational Biotechnology Company

GlobeNewswire November 16, 2020

LexaGene Announces Results of Annual General Shareholder's Meeting

GlobeNewswire November 13, 2020

LexaGene to Present at Two Upcoming Investor Conferences

GlobeNewswire November 10, 2020

LexaGene Provides a Corporate Update

GlobeNewswire October 5, 2020

LexaGene Engages Tailwinds Research Group

GlobeNewswire September 18, 2020

LexaGene Holdings Announces Closing of CAD$13.29 Million Financing

GlobeNewswire September 9, 2020

IIROC Trading Resumption - LXG

Canada NewsWire August 19, 2020

LexaGene Announces an Increase to Previously Announced Bought Deal Public Offering

Canada NewsWire August 19, 2020

IIROC Trading Halt - LXG

Canada NewsWire August 19, 2020

LexaGene Announces $7.5 Million Bought Deal Public Offering

Canada NewsWire August 18, 2020

LexaGene Engages Contract Manufacturer to Support Product Launch

GlobeNewswire August 17, 2020